Oxford Nanopore Technologies (ONT) Competitors GBX 143.58 -9.62 (-6.28%) (As of 12:27 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider Trades ONT vs. HEMO, BTG, ABC, GNS, ERGO, SLN, OXB, PRTC, HZD, and VRPShould you be buying Oxford Nanopore Technologies stock or one of its competitors? The main competitors of Oxford Nanopore Technologies include Hemogenyx Pharmaceuticals (HEMO), BTG (BTG), Abcam (ABC), Genus (GNS), Ergomed (ERGO), Silence Therapeutics (SLN), Oxford Biomedica (OXB), PureTech Health (PRTC), Horizon Discovery Group plc (HZD.L) (HZD), and Verona Pharma plc (VRP.L) (VRP). These companies are all part of the "biotechnology" industry. Oxford Nanopore Technologies vs. Hemogenyx Pharmaceuticals BTG Abcam Genus Ergomed Silence Therapeutics Oxford Biomedica PureTech Health Horizon Discovery Group plc (HZD.L) Verona Pharma plc (VRP.L) Hemogenyx Pharmaceuticals (LON:HEMO) and Oxford Nanopore Technologies (LON:ONT) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, community ranking, analyst recommendations, valuation, dividends, risk, profitability, earnings and media sentiment. Which has preferable valuation and earnings, HEMO or ONT? Hemogenyx Pharmaceuticals has higher earnings, but lower revenue than Oxford Nanopore Technologies. Hemogenyx Pharmaceuticals is trading at a lower price-to-earnings ratio than Oxford Nanopore Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHemogenyx PharmaceuticalsN/AN/A-£5.18M-£0.01-31,220.00Oxford Nanopore Technologies£167.75M8.06-£159.06M-£0.20-717.89 Do analysts prefer HEMO or ONT? Oxford Nanopore Technologies has a consensus target price of GBX 235.50, indicating a potential upside of 64.02%. Given Oxford Nanopore Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Oxford Nanopore Technologies is more favorable than Hemogenyx Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hemogenyx Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Oxford Nanopore Technologies 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is HEMO or ONT more profitable? Hemogenyx Pharmaceuticals has a net margin of 0.00% compared to Oxford Nanopore Technologies' net margin of -94.82%. Oxford Nanopore Technologies' return on equity of -26.08% beat Hemogenyx Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Hemogenyx PharmaceuticalsN/A -155.97% -37.79% Oxford Nanopore Technologies -94.82%-26.08%-14.42% Which has more volatility and risk, HEMO or ONT? Hemogenyx Pharmaceuticals has a beta of 3.14, indicating that its stock price is 214% more volatile than the S&P 500. Comparatively, Oxford Nanopore Technologies has a beta of 0.8, indicating that its stock price is 20% less volatile than the S&P 500. Do institutionals and insiders believe in HEMO or ONT? 0.8% of Hemogenyx Pharmaceuticals shares are owned by institutional investors. Comparatively, 38.4% of Oxford Nanopore Technologies shares are owned by institutional investors. 10.7% of Hemogenyx Pharmaceuticals shares are owned by company insiders. Comparatively, 32.6% of Oxford Nanopore Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the MarketBeat Community believe in HEMO or ONT? Hemogenyx Pharmaceuticals received 22 more outperform votes than Oxford Nanopore Technologies when rated by MarketBeat users. However, 100.00% of users gave Oxford Nanopore Technologies an outperform vote while only 57.89% of users gave Hemogenyx Pharmaceuticals an outperform vote. CompanyUnderperformOutperformHemogenyx PharmaceuticalsOutperform Votes5557.89% Underperform Votes4042.11% Oxford Nanopore TechnologiesOutperform Votes33100.00% Underperform VotesNo Votes Does the media refer more to HEMO or ONT? In the previous week, Oxford Nanopore Technologies had 1 more articles in the media than Hemogenyx Pharmaceuticals. MarketBeat recorded 3 mentions for Oxford Nanopore Technologies and 2 mentions for Hemogenyx Pharmaceuticals. Oxford Nanopore Technologies' average media sentiment score of 1.51 beat Hemogenyx Pharmaceuticals' score of -0.42 indicating that Oxford Nanopore Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hemogenyx Pharmaceuticals 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Oxford Nanopore Technologies 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive SummaryOxford Nanopore Technologies beats Hemogenyx Pharmaceuticals on 12 of the 17 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode.>> Register for the Workshop Now Get Oxford Nanopore Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ONT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ONT vs. The Competition Export to ExcelMetricOxford Nanopore TechnologiesBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£1.35B£197.59M£5.06B£1.41BDividend YieldN/A3.50%4.83%11.77%P/E Ratio-717.50316.46133.911,563.52Price / Sales8.0614,741.381,148.99297,901.50Price / Cash4.0411.6740.5633.22Price / Book2.187.344.762.87Net Income-£159.06M-£18.37M£118.62M£153.33M7 Day Performance-6.89%174.11%12.28%18.10%1 Month Performance14.40%125.29%12.40%18.15%1 Year Performance-25.99%111.17%31.63%23.31% Oxford Nanopore Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ONTOxford Nanopore Technologies2.9386 of 5 starsGBX 143.58-6.3%GBX 235.50+64.0%-20.0%£1.35B£167.75M-717.501,281Positive NewsHEMOHemogenyx PharmaceuticalsN/AGBX 378-10.0%N/A+15,117.4%£5.07BN/A-42,000.0014News CoverageGap DownBTGBTGN/AGBX 840+0.1%N/AN/A£3.26B£914.10M29.474,690ABCAbcamN/AGBX 1,226+11.2%N/AN/A£2.81B£350.40M20,433.331,650Gap UpHigh Trading VolumeGNSGenus2.3876 of 5 starsGBX 1,630-0.2%GBX 2,150+31.9%-24.8%£1.07B£668.80M13,616.67480ERGOErgomedN/AN/AN/AN/A£701.00M£152.09M4,641.386SLNSilence TherapeuticsN/AGBX 535-0.9%N/AN/A£480.35M£11.35M-11.01100Positive NewsHigh Trading VolumeOXBOxford Biomedica0.4655 of 5 starsGBX 423.50flatGBX 433.33+2.3%+112.6%£446.20M£97.28M-295.83891PRTCPureTech Health2.3772 of 5 starsGBX 170+4.4%GBX 455+167.6%+9.0%£407.01M£3.33M-745.89300Analyst ForecastNews CoverageHigh Trading VolumeHZDHorizon Discovery Group plc (HZD.L)N/AGBX 184.50flatN/AN/A£302.98M£54.63M-33.55416VRPVerona Pharma plc (VRP.L)N/AN/AN/A+0.0%£228MN/A-1.6822Gap Up Related Companies and Tools Related Companies Hemogenyx Pharmaceuticals Alternatives BTG Alternatives Abcam Alternatives Genus Alternatives Ergomed Alternatives Silence Therapeutics Alternatives Oxford Biomedica Alternatives PureTech Health Alternatives Horizon Discovery Group plc (HZD.L) Alternatives Verona Pharma plc (VRP.L) Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:ONT) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredAI Crypto Tool Could Send One Coin SOARING…The #1 AI Coin to Buy Rapid growth predicted for little-known AI crypto projectCrypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford Nanopore Technologies plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford Nanopore Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ONT Stock Alerts